Epidemiyolojide Gözlemsel Çalışmalar (Strobe Uzantı Rehberlerİ – 2)
Özet
Moleküler epidemiyoloji ve katılımcı odaklı örnekleme (RDS) çalışmalarında raporlama kalitesini artırmak amacıyla geliştirilen STROBE-ME ve STROBE-RDS uzantı rehberleri, bilimsel araştırmaların şeffaflığını ve tekrarlanabilirliğini sağlamayı hedefler. STROBE-ME, biyomarkerların seçimi, numune işleme süreçleri ve laboratuvar yöntemlerinin detaylandırılmasına odaklanırken; STROBE-RDS, ulaşılması zor popülasyonlarda kullanılan zincirleme örnekleme yönteminin metodolojik ayrıntılarını ve ağ boyutu analizlerini kapsar. Bu rehberler, karmaşık veri toplama ve analiz süreçlerinin asgari standartlarda raporlanması için araştırmacılara kapsamlı bir yol haritası sunarak bilimsel yayınların güvenilirliğine katkıda bulunur.
The STROBE-ME and STROBE-RDS extension guidelines focus on improving the transparency and reproducibility of molecular epidemiology and respondent-driven sampling (RDS) studies by enhancing reporting quality. While STROBE-ME details the selection of biomarkers, sample processing, and laboratory methods, STROBE-RDS covers the methodological specifics and network size analyses of chain-referral sampling used for hard-to-reach populations. These guidelines provide researchers with a comprehensive roadmap for reporting complex data collection and analysis processes at minimum standards, thereby contributing to the reliability of scientific publications.
Referanslar
Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007;85(11):867-872.
Little J, Higgins JP, Ioannidis JP, et al. STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement. Ann Intern Med. 2009;150(3):206-215.
Gallo V, Egger M, McCormack V, et al. STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement. PLoS Med. 2011;8(10):e1001117.
Biyomarkers&Human Biomonitoring: World Health Organisation (WHO); 2011 [Available from: https://www.who.int/publications/i/item/biomarkers-human-biomonitoring.
Van Duijn CM. STROBE-ME too! Eur J Epidemiol. 2011;26(10):761-762.
Sauerbrei W, Taube SE, McShane LM, et al. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration. J Natl Cancer Inst. 2018;110(8):803-811.
Avery L, Rotondi M. More comprehensive reporting of methods in studies using respondent driven sampling is required: a systematic review of the uptake of the STROBE-RDS guidelines. J Clin Epidemiol. 2020;117:68-77.
White RG, Hakim AJ, Salganik MJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: "STROBE-RDS" statement. J Clin Epidemiol. 2015;68(12):1463-1471.
Tyldum G. Surveying migrant populations with respondent-driven sampling. Experiences from surveys of east-west migration in Europe. Int J Soc Res Method. 2021;24(3):341-353.
Tucker JA, Bacon JP, Chandler SD, et al. Utility of digital Respondent Driven Sampling to recruit community-dwelling emerging adults for assessment of drinking and related risks. Addict Behav. 2020;110:106536.
Helms YB, Hamdiui N, Kretzschmar MEE, et al. Applications and Recruitment Performance of Web-Based Respondent-Driven Sampling: Scoping Review. Journal of Medical Internet Research. 2021;23(1):e17564.
Bauermeister JA, Zimmerman MA, Johns MM, et al. Innovative Recruitment Using Online Networks: Lessons Learned From an Online Study of Alcohol and Other Drug Use Utilizing a Web-Based, Respondent-Driven Sampling (webRDS) Strategy. J Stud Alcohol Drugs. 2012;73(5):834-838.
Yeka W, Maibani–Michie G, Prybylski D, et al. Application of Respondent Driven Sampling to Collect Baseline Data on FSWs and MSM for HIV Risk Reduction Interventions in Two Urban Centres in Papua New Guinea. Journal of Urban Health. 2006;83(S1):60-72.
Johnston LG, Whitehead S, Simic-Lawson M, et al. Formative research to optimize respondent-driven sampling surveys among hard-to-reach populations in HIV behavioral and biological surveillance: lessons learned from four case studies. AIDS Care. 2010;22(6):784-792.
Coetzee J, Buckley J, Otwombe K, et al. Depression and Post Traumatic Stress amongst female sex workers in Soweto, South Africa: A cross sectional, respondent driven sample. PLoS One. 2018;13(7):e0196759.
McCreesh N, Frost SDW, Seeley J, et al. Evaluation of Respondent-driven Sampling. Epidemiology. 2012;23(1):138-147.
Matiko E, Khatib A, Khalid F, et al. HIV Prevalence and Risk Behaviors Among People Who Inject drugs in Two Serial Cross-Sectional Respondent-Driven Sampling Surveys, Zanzibar 2007 and 2012. AIDS and Behavior. 2015;19(S1):36-45.
Wirtz AL, Iyer JR, Brooks D, et al. An evaluation of assumptions underlying respondent‐driven sampling and the social contexts of sexual and gender minority youth participating in HIV clinical trials in the United States. Journal of the International AIDS Society. 2021;24(5).
Theunissen K, Hoebe C, Kok G, et al. A Web—Based Respondent Driven Sampling Pilot Targeting Young People at Risk for Chlamydia Trachomatis in Social and Sexual Networks with Testing: A Use Evaluation. International Journal of Environmental Research and Public Health. 2015;12(8):9889-9906.
Bengtsson L, Lu X, Liljeros F, et al. Strong propensity for HIV transmission among men who have sex with men in Vietnam: behavioural data and sexual network modelling. BMJ Open. 2014;4(1):e003526.
Sharp MK, Hren D, Altman DG. The STROBE Extensions: Considerations for Development. Epidemiology. 2018;29(6):e53-e56.
Sharp MK, Glonti K, Hren D. Online survey about the STROBE statement highlighted diverging views about its content, purpose, and value. J Clin Epidemiol. 2020;123:100-106.
